In Re Mahurkar Double Lumen Hemodialysis Catheter Patent Litigation

140 B.R. 969, 23 U.S.P.Q. 2d (BNA) 1903, 1992 U.S. Dist. LEXIS 7559, 1992 WL 114897
CourtDistrict Court, N.D. Illinois
DecidedMay 28, 1992
DocketMDL 853
StatusPublished
Cited by53 cases

This text of 140 B.R. 969 (In Re Mahurkar Double Lumen Hemodialysis Catheter Patent Litigation) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Mahurkar Double Lumen Hemodialysis Catheter Patent Litigation, 140 B.R. 969, 23 U.S.P.Q. 2d (BNA) 1903, 1992 U.S. Dist. LEXIS 7559, 1992 WL 114897 (N.D. Ill. 1992).

Opinion

OPINION

EASTERBROOK, Circuit Judge. *

After a settlement between Vas-Cath and Mahurkar, the initial adversaries in this patent case, only two accused infring-ers remain as parties: IMPRA and Kendall Med-West, a division of The Kendall Company. We are in the final stages of discovery, with depositions by the dozen. Trial is set for August 10.

On May 20 Kendall and its parent filed bankruptcy petitions in the bankruptcy court for the District of Delaware. Kendall had been planning the step for more than a year in consort with its major lenders. Kendall filed a bankruptcy petition “prepackaged” with a plan of reorganization to which these creditors had assented. The proposed plan restructures Kendall’s debt obligations, which bear a rate of interest exceeding the going rate for money in the economy, while allowing all to avoid recognizing income (and paying tax) on the reduction of indebtedness.

Sakharam Mahurkar and Quinton Instruments Co., Kendall’s adversaries in this patent litigation, hold contingent debt claims against Kendall. They were left out *971 of the negotiations for the bankruptcy proceeding, first learning of the plans when they read an article in the Wall Street Journal. This court, too, was taken aback. Kendall did not mention the preparations at any time while the schedule was being discussed and set — did not mention it even by a secret filing that would have preserved whatever confidences were important to the plan. Instead Kendall took everyone by surprise, filing its papers in Delaware, walking out of the ongoing deposition of Dr. Mahurkar, and faxing this court (and its adversaries) a notice.

Kendall is standing on its rights under the automatic stay, 11 U.S.C. § 362, even though it says it expects the plan of reorganization to be approved by the end of June. According to the plan of reorganization, claims such as Mahurkar’s will pass through unaffected. Kendall’s action nonetheless throws the schedule in this court out of whack, awarding itself the extension that I have repeatedly refused to grant and raising questions about whether Kendall will be able to catch up in time to join the trial in August.

Although the automatic stay halts only litigation against the debtor in bankruptcy, Kendall instructed a former employee not to attend his deposition. Apparently in anticipation of the filing in Delaware, Kendall’s lawyer instructed one of its current employees not to answer certain financial questions during a deposition, although this court, consonant with Fed.R.Civ.P. 30(c) (“Evidence objected to shall be taken subject to the objections.”), had told counsel not to instruct witnesses to refrain from answering on any ground other than an assertion of privilege. I had offered to resolve disputes of any other kind by telephone to avoid exactly the sort of interruption that has occurred. Kendall’s instruction not to answer had no support in § 362, for Kendall had not yet filed its petition in bankruptcy.

Disturbed by these tactics, Dr. Mahurkar filed a motion on May 21 seeking an order that Kendall cease its interference with discovery pertinent to the ongoing litigation with IMPRA. Recognizing the force of § 362, Mahurkar conceded that his dispute in this forum with Kendall is in stasis, insofar as he seeks damages. But, citing numerous cases, Mahurkar asked me to rule that the automatic stay does not bar continued proceedings concerning Kendall’s request for a declaratory judgment (on the ground that this is an action by rather than against the debtor) or his own counterclaim for an injunction, to the extent that Kendall’s (asserted) infringement continues during the pendency of the bankruptcy proceeding. Naturally the first question is whether the forum in which an action is pending may decide for itself the effect of the automatic stay or instead whether the bankruptcy court has exclusive jurisdiction. Mahurkar cited a number of cases holding that the original forum may interpret § 362 and proceed to the extent that statute allows. Mahurkar asked me to do so.

On the afternoon of May 21 my staff called counsel for Kendall and instructed it to file a response by the close of business on May 26. Further conversations on May 22 conveyed to all counsel two additional decisions: Mahurkar’s reply brief would be due on May 27, and I would hold oral argument at 10:00 a.m. on May 28.

Kendall filed its brief on May 26, disputing Mahurkar’s interpretation of § 362. An orderly process was in train, leading to an orderly decision. Preferring a soliloquy to a dialog, Kendall began an adversary proceeding against Mahurkar and Quinton and at 2:30 p.m. on May 27 sought an ex parte order from the bankruptcy judge in Delaware. Mahurkar’s counsel in Chicago had enough notice to engage a lawyer in Wilmington and fax him some papers, which arrived at 1:00 p.m. on May 27. This lawyer appeared at the hearing but conceded that he lacked time to read the papers and knew next to nothing about the patent litigation. Quinton was unrepresented. Kendall asked the bankruptcy judge to enjoin Mahurkar from filing his reply brief or presenting his request for decision to this court. Kendall presented a draft order to bankruptcy judge Helen S. Balick, who dated and signed the draft, giving no written reasons. (Her brief oral statement also is sketchy.)

*972 What Kendall drafted for the bankruptcy judge contains formulaic and unreasoned recitations of irreparable harm (unfathomable, given that the expense of litigation is not irreparable injury, see Petroleum Exploration, Inc. v. Public Service Commission, 304 U.S. 209, 222, 58 S.Ct. 834, 841, 82 L.Ed. 1294 (1938); FTC v. Standard Oil Co., 449 U.S. 232, 244, 101 S.Ct. 488, 495, 66 L.Ed.2d 416 (1980); Renegotiation Board v. Bannercraft Clothing Co., 415 U.S. 1, 24, 94 S.Ct. 1028, 1040, 39 L.Ed.2d 123 (1974)) and contains these commands:

Defendants [Quinton and Mahurkar] are hereby ordered and/or restrained from taking any action or doing any act, other than by proper motion or other application before this Court to commence or continue any action against The Kendall Company, et al. in either the United States District Court for the Northern District of Illinois, Eastern Division, the United States District Court for the Central District of Utah, or the United States Bankruptcy Court for the District of Delaware with respect to the matters set out in the Patent Infringement Action, including, but not limited to, filing any reply brief, motions or memorandum of law, or conducting or participating in any type of discovery, except as to forthwith notify the Clerks of the courts listed above of the entry of an Order of this Court restraining any application by Quinton Instruments Company and/or Sakharam D.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Byline Bank v. Bank of America
2025 IL App (1st) 230927-U (Appellate Court of Illinois, 2025)
Kroft v. Viper Trans, Inc.
2025 IL App (1st) 240220 (Appellate Court of Illinois, 2025)
George Ryan Campbell
S.D. Mississippi, 2023
Thani A.T. Al Thani v. Hanke
S.D. New York, 2022
In re: Mark E. Stuart
Ninth Circuit, 2020
D/C Distribution, LLC
N.D. Illinois, 2020
In re Frantz
602 B.R. 687 (E.D. Wisconsin, 2019)
In re Ludkowski
587 B.R. 330 (N.D. Illinois, 2018)
In re Robinson
577 B.R. 294 (N.D. Illinois, 2017)
In re Whitlock-Young
571 B.R. 795 (N.D. Illinois, 2017)
In re Aguirre
548 B.R. 525 (N.D. Illinois, 2016)
In re Woods
517 B.R. 106 (N.D. Illinois, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
140 B.R. 969, 23 U.S.P.Q. 2d (BNA) 1903, 1992 U.S. Dist. LEXIS 7559, 1992 WL 114897, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-mahurkar-double-lumen-hemodialysis-catheter-patent-litigation-ilnd-1992.